Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

In Reply to Sari et al.

Autor: Aksnessæther BY; Department of Oncology, Ålesund Hospital, Møre and Romsdal Hospital Trust, Norway; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology, Trondheim, Norway., Myklebust TÅ; Department of Research and Innovation, Møre and Romsdal Hospital Trust, Norway; Department of Registration, Cancer Registry of Norway, Oslo, Norway., Solberg A; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology, Trondheim, Norway; Cancer Clinic, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Klepp OH; Department of Oncology, Ålesund Hospital, Møre and Romsdal Hospital Trust, Norway., Skovlund E; Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology, Trondheim, Norway., Hoff SR; Department of Radiology, Ålesund Hospital, Møre and Romsdal Hospital Trust, Ålesund, Norway; Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, NTNU, Trondheim, Norway., Fosså SD; Department of Oncology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Widmark A; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden., Lund JÅ; Department of Oncology, Ålesund Hospital, Møre and Romsdal Hospital Trust, Norway; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.

Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2020 Jun 01; Vol. 107 (2), pp. 388-389. Date of Electronic Publication: 2020 Feb 26.

Causes of inferior relative survival after testicular germ cell tumor diagnosed 1953-2015: A population-based prospective cohort study.

Autor: Kvammen Ø; Department of Oncology, Ålesund Hospital, Ålesund, Norway.; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway., Myklebust TÅ; Department of Research and Innovation, Møre and Romsdal Hospital Trust, Ålesund, Norway.; Department of Registration, Cancer Registry of Norway, Oslo, Norway., Solberg A; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.; The Cancer Clinic, St. Olav´s University Hospital, Trondheim, Norway., Møller B; Department of Registration, Cancer Registry of Norway, Oslo, Norway., Klepp OH; Department of Oncology, Ålesund Hospital, Ålesund, Norway., Fosså SD; National Advisory Unit on Late Effects after Cancer Treatment, Oslo University Hospital, The Radium Hospital, Oslo, Norway.; Faculty of Medicine, Oslo University, Oslo, Norway., Tandstad T; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.; The Cancer Clinic, St. Olav´s University Hospital, Trondheim, Norway.

Publikováno v: PloS one [PLoS One] 2019 Dec 18; Vol. 14 (12), pp. e0225942. Date of Electronic Publication: 2019 Dec 18 (Print Publication: 2019).

Does Prophylactic Radiation Therapy to Avoid Gynecomastia in Patients With Prostate Cancer Increase the Risk of Breast Cancer?

Autor: Aksnessæther BY; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway; Department of Oncology, Ålesund Hospital, Møre og Romsdal Hospital Trust, Ålesund, Norway. Electronic address: bjorg.y.aksnessether@helse-mr.no., Solberg A; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway; Cancer Clinic, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Klepp OH; Department of Oncology, Ålesund Hospital, Møre og Romsdal Hospital Trust, Ålesund, Norway., Myklebust TÅ; Department of Research and Innovation, Møre og Romsdal Hospital Trust, Ålesund, Norway; Department of Registration, Cancer Registry of Norway, Oslo, Norway., Skovlund E; Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway., Hoff SR; Department of Radiology, Ålesund Hospital, Møre og Romsdal Hospital Trust, Ålesund, Norway., Vatten LJ; Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway., Lund JÅ; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway; Department of Oncology, Ålesund Hospital, Møre og Romsdal Hospital Trust, Ålesund, Norway.

Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2018 May 01; Vol. 101 (1), pp. 211-216. Date of Electronic Publication: 2018 Feb 05.

Modern treatment of metastatic prostate cancer.

Autor: Holm HV; Kirurgisk avdeling Bærum sykehus., Dahl AA; Nasjonalt kompetansesenter for seneffekter etter kreftbehandling Oslo universitetssykehus, Radiumhospitalet., Klepp OH; Kreftavdelingen Helse Møre og Romsdal., Fosså SD; Nasjonalt kompetansesenter for seneffekter etter kreftbehandling Oslo universitetssykehus, Radiumhospitalet.

Publikováno v: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke [Tidsskr Nor Laegeforen] 2017 Jun 06; Vol. 137 (11), pp. 803-805. Date of Electronic Publication: 2017 Jun 06 (Print Publication: 2017).